Bases bibliographiques Pascal et Francis

Aide

Résultats de votre recherche

Votre recherche

ti.\*:("Targeted Therapies in the Treatment of Colorectal Cancer")

Discipline (document) [di]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Pays auteur

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Résultats 1 à 13 sur 13

  • Page / 1
Export

Sélection :

  • et

Targeted Therapies in the Treatment of Colorectal CancerO'DWYER, Peter J.Seminars in oncology. 2003, Vol 30, Num 3, issn 0093-7754, 94 p., SUP6Serial Issue

Optimal use of the combination of irinotecan and 5-fluorouracilBENSON, Al B; GOLDBERG, Richard M.Seminars in oncology. 2003, Vol 30, Num 3, pp 68-77, issn 0093-7754, 10 p., SUP6Article

Cyclooxygenase-2 inhibitors in colorectal cancerSTOEHLMACHER, Jan; LENZ, Heinz-Josef.Seminars in oncology. 2003, Vol 30, Num 3, pp 10-16, issn 0093-7754, 7 p., SUP6Article

Current status of oxaliplatin in colorectal cancerO'DWYER, Peter J; JOHNSON, Steven W.Seminars in oncology. 2003, Vol 30, Num 3, pp 78-87, issn 0093-7754, 10 p., SUP6Article

Development of ZD 1839 in colorectal cancerDOUGLASS, Edwin C.Seminars in oncology. 2003, Vol 30, Num 3, pp 17-22, issn 0093-7754, 6 p., SUP6Article

Practical considerations in the use of oral fluoropyrimidinesHOFF, Paulo Marcelo G.Seminars in oncology. 2003, Vol 30, Num 3, pp 88-92, issn 0093-7754, 5 p., SUP6Article

Inhibition of vascular endothelial growth factor in the treatment of colorectal cancerFERNANDO, Nishan H; HURWITZ, Herbert I.Seminars in oncology. 2003, Vol 30, Num 3, pp 39-50, issn 0093-7754, 12 p., SUP6Article

Development of the epidermal growth factor receptor inhibitor OSI-774GRÜNWALD, Viktor; HIDALGO, Manuel.Seminars in oncology. 2003, Vol 30, Num 3, pp 23-31, issn 0093-7754, 9 p., SUP6Article

The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cellsLONGLEY, Daniel B; LATIF, Tariq; BOYER, John et al.Seminars in oncology. 2003, Vol 30, Num 3, pp 3-9, issn 0093-7754, 7 p., SUP6Article

Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584THOMAS, Anne L; MORGAN, Bruno; DREVS, Joachim et al.Seminars in oncology. 2003, Vol 30, Num 3, pp 32-38, issn 0093-7754, 7 p., SUP6Article

EPO906 (epothilone B): A promising novel microtubule stabilizerROTHERMEL, John; WARTMANN, Markus; TIANLING CHEN et al.Seminars in oncology. 2003, Vol 30, Num 3, pp 51-55, issn 0093-7754, 5 p., SUP6Article

Signaling inhibition with radiation in colorectal cancer: Clinical trialsMCKENNA, W. Gillies; MUSCHEL, Ruth J; GUPTA, Anjali et al.Seminars in oncology. 2003, Vol 30, Num 3, pp 56-67, issn 0093-7754, 12 p., SUP6Article

Association de thérapies ciblées dans le traitement des cancers colorectaux : actualités et perspectives = Combination of targeted therapies in the treatment of colorectal cancerYCHOU, Marc.Hépato-gastro (Montrouge). 2008, Vol 15, Num SEPT, pp 32-35, issn 1253-7020, 4 p., NSArticle

  • Page / 1